EURETINA 2023: Safety and efficacy through week 48 in the Phase 2a STARLIGHT clinical trial

PHOTON Results and Their Relation to DME Patients in Your Practice

The IRIS is a cloud-based model that supports artificial intelligence-assisted diabetic retinopathy screening

Re-Vana Therapeutics and Boehringer Ingelheim announce collaboration, licensing partnership

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

Two people sit at a table. Their hands are visible, as are computers, pencils, notebooks, clipboards and documents. Concept image for business merger, licensing partnership, work collaboration, commercialisation throughout Europe, Re-Vana Therapeutics and Boehringer Ingelheim ocular eye drug therapy. Image credit: ©NAMPIX – stock.adobe.com

PULSAR Results and Their Relation to nAMD Patients in Your Practice

The companies will focus their joint effort on extended-release therapies for ocular disease

Alteogen receives positive CHMP opinion for aflibercept biosimilar EYLUXVI

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A photo of the European Medicines Agency (EMA) headquarters. Concept image for Alteogen aflibercept biosimilar approval, Committee for Medicinal Products for Human Use CHMP positive opinion for EYLUXVI. Image credit: ©Ogulcan Aksoy - SCA – stock.adobe.com

Martin David Harp

Fungal infection and vision impact in patients with diabetic eye disease

According to the company, the EMA’s opinion was based on the “totality of evidence comprising a comprehensive analytical, non-clinical and clinical data package”

A brain and a fungus mushroom both depicted in illustration. Concept image for fungal infection and diabetic eye disease. Image credit: ©Anson – stock.adobe.com – generated with AI

Topcon expands AI portfolio with Intelligent Retinal Imaging Systems acquisition

Rhino-orbital-cerebral mucormycosis, a life-threatening fungal infection, typically occurs in patients with diabetes

Related Content

Hattie Hayes

PHOTON Results and Their Relation to DME Patients in Your Practice

The IRIS is a cloud-based model that supports artificial intelligence-assisted diabetic retinopathy screening

Re-Vana Therapeutics and Boehringer Ingelheim announce collaboration, licensing partnership

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

PULSAR Results and Their Relation to nAMD Patients in Your Practice

The companies will focus their joint effort on extended-release therapies for ocular disease

Alteogen receives positive CHMP opinion for aflibercept biosimilar EYLUXVI

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

Martin David Harp

Fungal infection and vision impact in patients with diabetic eye disease

According to the company, the EMA’s opinion was based on the “totality of evidence comprising a comprehensive analytical, non-clinical and clinical data package”